AstraZeneca
AZN
$66.57
Share price
-0.63%
Change (1 day)
4.87%
Change (1 year)
Categories
P/S ratio for AstraZeneca (AZN)
P/S ratio as of March 2023 (TTM): 4.65
According to AstraZeneca's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.65265. At the end of 2022 the company had a P/S ratio of 4.74.
P/S ratio history for AstraZeneca from 2001 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 4.74 | -2.19% |
| 2021 | 4.85 | -1.45% |
| 2020 | 4.92 | -8.31% |
| 2019 | 5.37 | 25.56% |
| 2018 | 4.27 | 10.21% |
| 2017 | 3.88 | 29.36% |
| 2016 | 3.00 | -14.32% |
| 2015 | 3.50 | 1.95% |
| 2014 | 3.43 | 19.09% |
| 2013 | 2.88 | 37.53% |
| 2012 | 2.10 | 17.67% |
| 2011 | 1.78 | -8.96% |
| 2010 | 1.96 | -5.78% |
| 2009 | 2.08 | 10.47% |
| 2008 | 1.88 | -10.96% |
| 2007 | 2.11 | -31.88% |
| 2006 | 3.10 | -4.92% |
| 2005 | 3.26 | 16.72% |
| 2004 | 2.79 | -35.74% |
| 2003 | 4.35 | 27.74% |
| 2002 | 3.40 | -1.57% |
| 2001 | 3.46 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 4.96 | 6.67% | 🇺🇸 USA |
 Novartis NVS | 3.35 | -27.96% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.25 | -51.65% | 🇺🇸 USA |
 Abbott Laboratories ABT | 3.86 | -17.12% | 🇺🇸 USA |
 Eli Lilly LLY | 11.0 | 137.40% | 🇺🇸 USA |
 Sanofi SNY | 2.56 | -45.01% | 🇫🇷 France |
 Biogen BIIB | 3.72 | -20.02% | 🇺🇸 USA |
 Merck MRK | 4.47 | -3.90% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 3.06 | -34.30% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 1.84 | -60.49% | 🇬🇧 UK |